Effects and mechanisms of liraglutide in ameliorating liver fibrosis in NAFLD mice

Effects and mechanisms of liraglutide in ameliorating liver fibrosis in NAFLD mice

Objective·To investigate the effects of liraglutide on liver fibrosis in mice with non-alcoholic fatty liver disease (NAFLD) and the underlying mechanisms.Methods·Twenty 8-week-old C57BL/6J mice were randomly divided into a normal chow diet group (Chow group) and a methionine-choline-deficient (MCD)...

Full description

Saved in:

Bibliographic Details
Main Authors:	WANG Renjie, ZHU Chaoyu, FANG Yunyun, XIAO Yuanyuan, WANG Qianqian, SONG Wenjing, WEI Li
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Shanghai Jiao Tong University (Medical Science) 2025-04-01
Series:	Shanghai Jiaotong Daxue xuebao. Yixue ban
Subjects:	liraglutide transforming growth factor-β (tgf-β) sma- and mad-related protein 3 (smad3) non-alcoholic fatty liver disease liver fibrosis
Online Access:	https://xuebao.shsmu.edu.cn/article/2025/1674-8115/1674-8115-2025-45-4-415.shtml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mechanisms of the TGF-β1/Smad3-signaling pathway in gender differences in alcoholic liver fibrosis
by: Xiaomin Hong, et al.
Published: (2024-02-01)

Preclinical validation of TGFβ inhibitors as a novel therapeutic strategy for post-traumatic heterotopic ossification
by: Jaira Ferreira de Vasconcellos, et al.
Published: (2025-04-01)

Inhibitory effect of melatonin on peritoneal fibrosis in rats and its mechanism
by: ZHAO Hua, et al.
Published: (2017-01-01)

Liraglutide inhibits the development of colorectal cancer by regulating TGF-β/Smad3 signaling pathway and affecting epithelial-mesenchymal transition
by: Xinjian Li, et al.
Published: (2025-07-01)

OTUD3 inhibits breast cancer cell metastasis by regulating TGF-β pathway through deubiquitinating SMAD7
by: Chenchen Geng, et al.
Published: (2025-05-01)

Aging increases susceptibility to liver fibrosis through enhanced NAT10-mediated ac4C modification of TGFβ1 mRNA
by: Xuyun Peng, et al.
Published: (2025-08-01)

Allicin induced AMPK signaling attenuated Smad3 pathway mediated lung fibrosis
by: Shun Nakazawa, et al.
Published: (2025-05-01)

Dapagliflozin inhibits ferroptosis and ameliorates renal fibrosis in diabetic C57BL/6J mice
by: Zhen Zhang, et al.
Published: (2025-02-01)

CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism
by: Mian Liu, et al.
Published: (2025-07-01)

Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2022-09-01)

Corrigendum: Endoglin aggravates peritoneal fibrosis by regulating the activation of TGF-β/ALK/Smads signaling
by: Qian Huang, et al.
Published: (2024-12-01)

UHRF1 promotes epithelial-mesenchymal transition mediating renal fibrosis by activating the TGF-β/SMAD signaling pathway
by: Lijie Yang, et al.
Published: (2025-01-01)

Anti-fibrosis effect of astragaloside IV in animal models of cardiovascular diseases and its mechanisms: a systematic review
by: Shiyu Zhang, et al.
Published: (2025-12-01)

The promotive role of reticulocalbin 3 (RCN3) in the pathogenesis of keloid via TGFβ1/Smad2/Smad7 signaling pathway in vitro
by: Wang HongYu, et al.
Published: (2024-12-01)

TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
by: Weili Wang, et al.
Published: (2025-06-01)

Tanshinone IIA alleviates liver fibrosis by suppressing hepatic stellate cell proliferation via ERK/cyclin D1/p-Smad3L signaling axis
by: Wenjing Liao, et al.
Published: (2025-05-01)

Effects of melatonin on peritoneal fibrosis induced by high glucose peritoneal dialysis in rats
by: XING Bei-bei, et al.
Published: (2016-01-01)

Exploration of the mechanism of NORAD activation of TGF-β1/Smad3 through miR-136-5p and promotion of tacrolimus-induced renal fibrosis
by: Lei Liu, et al.
Published: (2023-12-01)

Qinggan Yipi capsule ameliorates hepatic fibrosis in rats by down-regulating the TGF-β1/Smad2/3 signaling pathway and improving gut microbiota imbalance
by: Wenjing Xue, et al.
Published: (2025-01-01)

Ivermectin Attenuates Methotrexate-Induced Liver Fibrosis by Reducing TGF-β and Syndecan-1 Expression
by: Cengiz Dibekoğlu, et al.
Published: (2025-06-01)

Inhibitory effects of oxyresveratrol on ERK and Smad1/2 phosphorylation and HSC activation in preventing carbon tetrachloride-induced rat liver fibrosis
by: Guliang Yang, et al.
Published: (2021-01-01)

Targeted Delivery of Bortezomib Using Retinoid-Based Nanoparticle: Modulating Liver Fibrosis through the TGF-β1/Smad3 Pathway
by: Samaneh Siapoush, et al.
Published: (2025-04-01)

Lentivirus-Mediated Missense Mutation in HtrA1 Leads to Activation of the TGF-β/Smads Pathway and Increased Apoptosis of Mouse Brain Microvascular Endothelial Cells via the Oxidative Stress Pathway
by: Shi-na Song, et al.
Published: (2024-10-01)

Multiomic characterization, immunological and prognostic potential of SMAD3 in pan-cancer and validation in LIHC
by: Tao Zhou, et al.
Published: (2025-01-01)

Spermine: A prospective treatment for high glucose-induced myocardial fibrosis in db/db mice
by: Yong Liu, et al.
Published: (2025-07-01)

Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
by: Yuan-Yuan Xu, et al.
Published: (2024-09-01)

Quercetin mitigates hepatic injury by inhibiting TGF-β/p-Smad3 signaling pathway activation and enhancing AMPK activity in type 2 diabetic rats
by: Hanaa F. B. Gaber, et al.
Published: (2025-04-01)

Paridis Rhizoma Saponins ameliorate CCl4-induced liver fibrosis via modulation of the Nrf2-HO-1/NQO-1 and TGF-β1/Smads signaling pathways
by: Yan Hong, et al.
Published: (2025-06-01)

Rudhira-mediated microtubule stability controls TGFβ signaling during mouse vascular development
by: Divyesh Joshi, et al.
Published: (2025-05-01)

Experimental study of artesunate ameliorating head-and-neck radiation-induced skin fibrosis in rats through inhibiting Stat3/TGF-β1 signaling pathway
by: TANG Chan, et al.
Published: (2025-04-01)

FSTL1 accelerates nucleus pulposus-derived mesenchymal stem cell apoptosis in intervertebral disc degeneration by activating TGF-β-mediated Smad2/3 phosphorylation
by: Xu Yan, et al.
Published: (2025-02-01)

Panaxatriol saponins exert anti-renal fibrosis by suppressing TNF-α mediated inflammation and TGF-β1/Smad3 signaling pathway
by: Si Yi, et al.
Published: (2025-12-01)

Quantitative analysis of transient and sustained transforming growth factor‐β signaling dynamics
by: Zhike Zi, et al.
Published: (2011-05-01)

SQLE promotes osteosarcoma progression via activating TGFβ/SMAD signaling pathway
by: Qi Song, et al.
Published: (2024-12-01)

Effect of resveratrol on key signaling pathways including SIRT1/AMPK/Smad3/TGF-β and miRNA-141 related to NAFLD in an animal model
by: Sahar Yarahmadi, et al.
Published: (2025-05-01)

Role of the TGF-β/Smad3 pathway in pancreatic cancer cell growth and stem cell characteristics
by: Yanling Zhang, et al.
Published: (2025-08-01)

Cathepsin B Levels Correlate with the Severity of Canine Myositis
by: Valeria De Pasquale, et al.
Published: (2025-05-01)

Ursolic Acid Inhibits Collagen Production and Promotes Collagen Degradation in Skin Dermal Fibroblasts: Potential Antifibrotic Effects
by: Tianyuan He, et al.
Published: (2025-03-01)

DsbA-L activates TGF-β1/SMAD3 signaling and M2 macrophage polarization by stimulating AKT1 and NLRP3 to promote pulmonary fibrosis
by: Juan Wang, et al.
Published: (2024-11-01)

Syndecan-4 promotes gastric cancer progression through activating TGF-β1 induced lipid reprogramming and contributes positive loop circuits
by: Guangjie Liu, et al.
Published: (2025-06-01)